Experimental infection with bovine herpesvirus-4 enhances atherosclerotic process in rabbits

Laboratory Investigation

Volumn 80, Issue 1, 2000, Pages 3-11

  Lin, Tsun Mei ^a   Jiang, Meei Jyh ^a   Eng, Hock Liew ^b   Shi, Guey Yueh ^a   Lai, Lin Chun ^a   Huang, Bor Jang ^a   Huang, Kun Yen ^a   Wu, Hua Lin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HERPES; HERPES VIRUS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033958023     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780002     Document Type: Article

References (43)

1. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, and DeBakey ME (1987). High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2:291-293.
2. Almendral JM, Blasco R, Ley V, Beloso A, Talavera A, and Vinuela E (1984). Restriction site map of African swine fever virus DNA. Virology 133:258-270.
3. Bublot M, Lomonte P, Lequarre AS, Albrecht JC, Nicholas J, Fleckenstein B, Pastoret PP, and Thiry E (1992). Genetic relationships between bovine herpesvirus 4 and the gamma-herpesviruses Epstein-Barr virus and herpesvirus Saimiri. Virology 190:654-665.
4. Campbell JH and Campbell GR (1994). Cell biology of atherosclerosis. J Hypertension 12(Suppl 10):S129-S132.
5. Castrucci G, Frigeri F, Ferrari M, Di Luca D, and Traldi V (1991). A study of some biologic properties of bovid herpesvirus-4. Comp Immun Microbiol Infect Dis 14:197-207.
6. Chang WC, Chen SH, Wu HL, Shi GY, Murota S, and Morita I (1991). Cytoprotective effect of reduced glutathione in arsenical-induced endothelial cell injury. Toxicology 69:101-110.
7. Cone RW, Hobson AC, and Huang MLW (1992). Coamplified positive control detects inhibition of polymerase chain reactions. J Clin Microbiol 30:3185-3189.
8. Egyed L, Ballagi-Pordany A, Bartha A, and Belak S (1996). Studies of in vivo distribution of bovine herpesvirus type 4 in the natural host. J Clin Microbiol 34:1091-1095.
9. Egyed L and Bartha A (1998). PCR studies on the potential sites for latency of BHV-4 in calves. Vet Res Commun 22:209-216.
10. Fabricant CG, Fabricant J, Litrenta MM, and Minick CR (1978). Virus-induced atherosclerosis. J Exp Med 148:335-340.
11. Folch J, Lees M, and Stanley GHS (1957). A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509.
12. Geer JC and Malcom GT (1965). Cholesterol ester fatty acid composition of human aorta fatty streaks and normal intima. Exp Mol Pathol 4:500-507.
13. Hajjar DP, Fabricant CG, Minick CR, and Fabricant J (1986). Virus-induced atherosclerosis: Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 122:62-70.
14. Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, and Grant AJ (1987). Herpes simplex virus infection in human arterial cells: Implications in arteriosclerosis. J Clin Invest 80:1317-1321.
15. Insull WJ and Bartsch GE (1966). Cholesterol, triglyceride, and phospholipid content of intima, media, and atherosclerotic fatty streak in human thoracic aorta. J Clin Invest 45:513-523.
16. Kannel WB, McGee D, and Gordon T (1976). A general cardiovascular risk profile: The Framingham study. Epidemiology 38:46-51.
17. Lin TM, Shi GY, Tsai CF, Su HJ, Guo YLL, and Wu HL (1997). Susceptibility of endothelial cells to bovine herpesvirus type 4 (BHV-4). J Virol Meth 63:219-225.
18. Lopez OJ, Galeota JA, and Osorio FA (1996). Bovine herpesvirus type-4 (BHV-4) persistently infects cells of the marginal zone of spleen in cattle. Microb Pathogen 21:47-58.
19. Ludwig H (1983). Bovine herpesviruses. In: Roizman B, editor. The herpesviruses. New York: Plenum Press, pp 135-214.
20. Massy ZA and Keane WF (1996). Pathogenesis of atherosclerosis. Sem Nephrol 16:12-20.
21. Melnick JL, Adam E, and Debakey ME (1993). Cytomegalovirus and atherosclerosis. Eur Heart J 14:30-38.
22. Melnick JL, Adam E, and DeBakey ME (1995). Cytomegalovirus and atherosclerosis. BioEssays 17:899-903.
23. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, and DeBakey ME (1983). Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2:644-647.
24. Minick CR, Fabricant CG, Fabricant J, and Litrenta MM (1979). Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol 96:673-706.
25. Morita I, Kanayasu T, and Murota S (1984). Kallikrein stimulates prostacyclin production in bovine vascular endothelial cells. Biochim Biophys Acta 792:304-309.
26. Naeem K, Caywood DD, Werdin RE, and Goyal SM (1990). Evaluation of pregnant rabbits as a laboratory model for bovid herpesvirus-4 infection. Am J Vet Res 51:640-644.
27. Naeem K, Murtaugh MP, and Goyal SM (1991). Tissue distribution of bovid herpesvirus-4 inoculated rabbits and its detection by DNA hybridization and polymerase chain reaction. Arch Virol 119:239-255.
28. Nicholson AC and Hajjar DP (1998). Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vas Biol 18:339-348.
29. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, and Szklo M (1996). Cohort study of cytomegalovirus infection as a risk factor for, carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94:922-927.
30. Osorio FA and Reed DE (1983). Experimental inoculation of cattle with bovine herpesvirus-4: evidence for a lymphoid-associated persistent infection. Am J Vet Res 44:975-780.
31. Osorio FA, Reed DE, and Rock DL (1982). Experimental infection of rabbits with bovine herpesvirus-4: Acute and persistent infection. Vet Microbiol 7:503-513.
32. Osorio FA, Rock DL, and Reed DE (1985). Studies on the pathogenesis of a bovine cytomegalo-like virus in an experimental host. J Gen Virol 66:1941-1951.
33. Persoons MC, Daemen MJ, Bruning JH, and Bruggeman CA (1994). Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats: A clue to herpesvirus-associated atherogenesis? Cir Res 75:214-220.
34. Petrie BL, Melnick JL, Adam E, Burek J, McCollum CH, and DeBakey ME (1987). Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue. J Infect Dis 155:158-159.
35. Ross R (1986). The pathogenesis of atherosclerosis. N Engl J Med 314:488-500.
36. Ross R (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809.
37. Ross R and Glomset JA (1976). The pathogenesis of atherosclerosis. N Engl J Med 295:369-377, 420-425.
38. Schwenk E and Stevens DF (1960). Deposition of cholesterol in experimental rabbit atherosclerosis. Proc Soc Exp Biol Med 103:614-617.
39. Span AHM, Grauls G, Bosman F, van Boven CPA, and Bruggeman CA (1992). Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis 93:41-52.
40. Staczek J (1990). Animal cytomegaloviruses. Microbiol Rev 54:247-265.
41. Storz J, Ehlers B, Todd WJ, and Ludwig H (1984). Bovine cytomegaloviruses: Identification and differential properties. J Gen Virol 65:697-706.
42. Thiry E, Bublot M, Dubuisson J, and Pastoret PP (1989). Bovine herpesvirus-4 (BHV-4) infections in cattle. In: Wittmann G, editor. Herpesvirus diseases of cattle, horses, and pigs. Boston: Kluwer Press, pp 96-115.
43. Zilversmit DB, Sweeley CC, and Newman HA (1961). Fatty acid composition of serum and aortic intimai lipids in rabbits fed low-and high-cholesterol diets. Circ Res 9:235-241.